Evaluation of Anti-HIF and Anti-Angiogenic Properties of Honokiol for the Treatment of Ocular Neovascular Diseases
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of Anti-HIF and Anti-Angiogenic Properties of Honokiol for the Treatment of Ocular Neovascular Diseases
Authors
Keywords
Hypoxia, Enzyme-linked immunoassays, Angiogenesis, Endothelial cells, Oxygen, Vasculogenesis, Ophthalmology, Placental growth factor
Journal
PLoS One
Volume 9, Issue 11, Pages e113717
Publisher
Public Library of Science (PLoS)
Online
2014-11-26
DOI
10.1371/journal.pone.0113717
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge
- (2013) Giacomo Cavallaro et al. ACTA OPHTHALMOLOGICA
- Honokiol inhibits pathological retinal neovascularization in oxygen-induced retinopathy mouse model
- (2013) Divya Teja Vavilala et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas
- (2013) V.K. Chaithanya Ponnaluri et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ocular neovascularization
- (2013) Peter A. Campochiaro JOURNAL OF MOLECULAR MEDICINE-JMM
- Honokiol inhibits HIF pathway and hypoxia-induced expression of histone lysine demethylases
- (2012) Divya Teja Vavilala et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Berberine Modulates Epigenetics via Inhibition of Hypoxia-Induced Histone Lysine Demethylases Expression
- (2012) Divya Teja Vavilala et al. DRUG DEVELOPMENT RESEARCH
- The Expanding Role of Vascular Endothelial Growth Factor Inhibitors in Ophthalmology
- (2012) Michael W. Stewart MAYO CLINIC PROCEEDINGS
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
- (2012) Gregg L. Semenza TRENDS IN PHARMACOLOGICAL SCIENCES
- Hypoxia induced expression of histone lysine demethylases: Implications in oxygen-dependent retinal neovascular diseases
- (2011) V.K. Chaithanya Ponnaluri et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Synthesis and neurite growth evaluation of new analogues of honokiol, a neolignan with potent neurotrophic activity
- (2011) Vemula Praveen Kumar et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- An expedient synthesis of honokiol and its analogues as potential neuropreventive agents
- (2011) Subhankar Tripathi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway
- (2011) L Qiang et al. CELL DEATH AND DIFFERENTIATION
- Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
- (2011) Yin Wang et al. Cell Stem Cell
- Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1 in Advanced Solid Tumors
- (2011) S. Kummar et al. CLINICAL CANCER RESEARCH
- Microtubule disruption targets HIF-1α mRNA to cytoplasmic P-bodies for translational repression
- (2011) Marisa Carbonaro et al. JOURNAL OF CELL BIOLOGY
- Therapeutic applications of compounds in the Magnolia family
- (2011) Young-Jung Lee et al. PHARMACOLOGY & THERAPEUTICS
- Antitumor agent PX-12 inhibits HIF-1α protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase
- (2010) Yon Hui Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1α
- (2010) Sreenivasulu Chintala et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1 Expression in an AhR-Independent Fashion
- (2010) E. Terzuoli et al. CANCER RESEARCH
- Digoxin inhibits retinal ischemia-induced HIF-1α expression and ocular neovascularization
- (2010) Tsunehiko Yoshida et al. FASEB JOURNAL
- Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy
- (2009) H Harada et al. BRITISH JOURNAL OF CANCER
- HIF at a glance
- (2009) M. C. Brahimi-Horn et al. JOURNAL OF CELL SCIENCE
- Pleiotropic Effects of YC-1 Selectively Inhibit Pathological Retinal Neovascularization and Promote Physiological Revascularization in a Mouse Model of Oxygen-Induced Retinopathy
- (2009) M. DeNiro et al. MOLECULAR PHARMACOLOGY
- Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis
- (2009) Kip M Connor et al. Nature Protocols
- mTOR and HIF-1 -mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome
- (2009) D. B. Shackelford et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells
- (2009) K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
- (2009) K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biology of hypoxia-inducible factor-2α in development and disease
- (2008) S A Patel et al. CELL DEATH AND DIFFERENTIATION
- A RNA antagonist of hypoxia-inducible factor-1 , EZN-2968, inhibits tumor cell growth
- (2008) L. M. Greenberger et al. MOLECULAR CANCER THERAPEUTICS
- Digoxin and other cardiac glycosides inhibit HIF-1 synthesis and block tumor growth
- (2008) H. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now